Advertisement

Abstract

Radical surgery is the only therapeutic option that can ensure a long-term survival; until now many aspects of this disease have not been well-known, such as pathogenesis, and clinical and histopathologic factors that determine survival. In this chapter we will analyze the main prognostic factors that influence survival: macroscopic aspect, local extent, lymph-node involvement and distant metastases. Histological characteristics and molecular factors related to prognosis will also be analysed.

Keywords

Bile Duct Extrahepatic Bile Duct Biliary Tract Cancer Hilar Cholangiocarcinoma Bile Duct Cancer 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Hoang MP, Murakata LA, Katabi N et al. (2002) Invasive papillary carcinomas of the extrahepatic bile ducts: a clinicopathologic and immunohistochemical study of 13 cases. Mod Pathol 15(12):1251–1258PubMedCrossRefGoogle Scholar
  2. 2.
    Albores-Saavedra J, Murakata L, Krueger JE, Henson DE (2000) Noninvasive and minimally invasive papillary carcinomas of the extrahepatic bile ducts. Cancer 89(3):508–515PubMedCrossRefGoogle Scholar
  3. 3.
    Sakamoto E, Nimura Y, Hayakawa N et al (1998) The pattern of infiltration at the proximal border of hilar bile duct carcinoma: a histologic analysis of 62 resected cases. Ann Surg 227(3):405–411PubMedCrossRefGoogle Scholar
  4. 4.
    Jarnagin WR, Bowne W, Klimstra DS et al (2005) Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma. Ann Surg 241(5):703–712; discussion 712–714PubMedCrossRefGoogle Scholar
  5. 5.
    Dinant S, Gerhards MF, Rauws EA et al (2006) Improved outcome of resection of hilar cholangiocarcinoma (Klatskin tumour). Ann Surg Oncol 13(6):872–80PubMedCrossRefGoogle Scholar
  6. 6.
    Kondo S, Hirano S, Ambo Y et al (2004) Forty consecutive resections of hilar cholangiocarcinoma with no postoperative mortality and no positive ductal margins: results of a prospective study. Ann Surg 240(1):95–101PubMedCrossRefGoogle Scholar
  7. 7.
    Neuhaus P, Jonas S, Bechstein WO et al (1999) Extended resections for hilar cholangiocarcinoma. Ann Surg 230(6):808–818; discussion 819PubMedCrossRefGoogle Scholar
  8. 8.
    Bhuiya MR, Nimura Y, Kamiya J et al (1992) Clinicopathologic studies on perineural invasion of bile duct carcinoma. Ann Surg 215(4):344–349PubMedCrossRefGoogle Scholar
  9. 9.
    Ebata T, Nagino M, Kamiya J et al (2003) Hepatectomy with portal vein resection for hilar cholangiocarcinoma: audit of 52 consecutive cases. Ann Surg 238(5):720–727PubMedCrossRefGoogle Scholar
  10. 10.
    Liu XF, Zhang H, Zhu SG et al (2006) Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma. World J Gastroenterol 12(29):4706–4709PubMedGoogle Scholar
  11. 11.
    Jarnagin WR, Klimstra DS, Hezel M et al (2006) Differential cell cycle-regulatory protein expression in biliary tract adenocarcinoma: correlation with anatomic site, pathologic variables, and clinical outcome. J Clin Oncol 24(7):1152–1160PubMedCrossRefGoogle Scholar
  12. 12.
    Zervos EE, Osborne D, Goldin SB et al (2005) Stage does not predict survival after resection of hilar cholangiocarcinomas promoting an aggressive operative approach. Am J Surg 190(5):810–815PubMedCrossRefGoogle Scholar
  13. 13.
    Itoi T, Shinohara Y, Takeda K et al (2000) Detection of telomerase activity in biopsy specimens for diagnosis of biliary tract cancers. Gastrointest Endocs 52(3)380–386CrossRefGoogle Scholar
  14. 14.
    Abdalla EK, Vauthey JN (2001) Biliary tract cancer. Curr Opin Gastroenterol 17(5):450–457PubMedCrossRefGoogle Scholar
  15. 15.
    Rajala RV, Radhi JM, Kakkar R et al (2000) Increased expression of N-myristoyltransferase in gallbladder carcinomas. Cancer 88(9):1992–1999PubMedCrossRefGoogle Scholar
  16. 16.
    Cormier JN, Vauthey JN (2000) Biliary tract cancer. Curr Opin Gastroenterol 16(5):437–443PubMedCrossRefGoogle Scholar
  17. 17.
    Rashid A, Ueki T, Gao YT et al (2002) K-ras mutation, p53 overexpression, and microsatellite instability in biliary tract cancers: a population-based study in China. Clin Cancer Res 8(10):3156–3163PubMedGoogle Scholar
  18. 18.
    Hong SM, Cho H, Moskaluk CA, Yu E (2007) Measurement of the invasion depth of extrahepatic bile duct carcinoma: an alternative method overcoming the current T classification problems of the AJCC staging system. Am J Surg Pathol 31(2):199–206PubMedCrossRefGoogle Scholar
  19. 19.
    Tabata M, Kawarada Y, Yokoi H et al (2000) Surgical treatment for hilar cholangiocarcinoma. J Hepatobiliary Pancreat Surg 7(2):148–154PubMedCrossRefGoogle Scholar
  20. 20.
    Cha JM, Kim MH, Lee SK et al (2006) Clinicopathological review of 61 patients with early bile duct cancer. Clin Oncol (R Coll Radiol) 18(9):669–677Google Scholar
  21. 21.
    Mizumoto R, Ogura Y, Kusuda T (1993) Definition and diagnosis of early cancer of the biliary tract. Hepatogastroenterology 40(1):69–77PubMedGoogle Scholar
  22. 22.
    Kurosaki I, Tsukada K, Watanabe H, Hatakeyama K (1998) Prognostic determinants in extrahepatic bile duct cancer. Hepatogastroenterology 45(22):905–909PubMedGoogle Scholar
  23. 23.
    Bhuiya MR, Nimura Y, Kamiya J et al (1993) Clinicopathologic factors influencing survival of patients with bile duct carcinoma: multivariate statistical analysis. World J Surg 17(5):653–657PubMedCrossRefGoogle Scholar
  24. 24.
    Hong SM, Kim MJ, Pi DY et al (2005) Analysis of extrahepatic bile duct carcinomas according to the New American Joint Committee on Cancer staging system focused on tumour classification problems in 222 patients. Cancer 104(4):802–810PubMedCrossRefGoogle Scholar
  25. 25.
    Nishio H, Nagino M, Oda K et al (2005) TNM classification for perihilar cholangiocarcinoma: comparison between 5th and 6th editions of the AJCC/UICC staging system. Langenbecks Arch Surg 390(4):319–327PubMedCrossRefGoogle Scholar
  26. 26.
    Kitagawa Y, Nagino M, Kamiya J et al (2001) Lymph-node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection. Ann Surg 233(3):385–392PubMedCrossRefGoogle Scholar
  27. 27.
    Nakeeb A, Pitt HA, Sohn TA et al (1996) Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumours. Ann Surg 224(4):463–473; discussion 473–475PubMedCrossRefGoogle Scholar
  28. 28.
    Sugiura Y, Nakamura S, Iida S et al (1994) Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery 115(4):445–451PubMedGoogle Scholar
  29. 29.
    Iwatsuki S, Todo S, Marsh JW et al (1998) Treatment of hilar cholangiocarcinoma (Klatskin tumours) with hepatic resection or transplantation. J Am Coll Surg 187(4):358–364PubMedCrossRefGoogle Scholar
  30. 30.
    Ogura Y, Kawarada Y (1998) Surgical strategies for carcinoma of the hepatic duct confluence. Br J Surg 85(1):20–24PubMedCrossRefGoogle Scholar
  31. 31.
    Miyazaki M, Ito H, Nakagawa K et al (1999) Parenchyma-preserving hepatectomy in the surgical treatment of hilar cholangiocarcinoma. J Am Coll Surg 189(6):575–583PubMedCrossRefGoogle Scholar
  32. 32.
    Kosuge T, Yamamoto J, Shimada K et al (1999) Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Ann Surg 230(5):663–671PubMedCrossRefGoogle Scholar
  33. 33.
    Miyazaki M, Kato A, Ito H et al (2007) Combined vascular resection in operative resection for hilar cholangiocarcinoma: does it work or not? Surgery 141(5):581–588PubMedCrossRefGoogle Scholar
  34. 34.
    Hemming AW, Reed AI, Fujita S et al (2005) Surgical management of hilar cholangiocarcinoma. Ann Surg 241(5):693–699; discussion 699–702PubMedCrossRefGoogle Scholar
  35. 35.
    Launois B, Terblanche J, Lakehal M et al (1999) Proximal bile duct cancer: high resectability rate and 5-year survival. Ann Surg 230(2):266–275PubMedCrossRefGoogle Scholar
  36. 36.
    Nagakawa T, Kayahara M, Ikeda S et al 0 Bilary tract cancer treatment: results from the Biliary Tract Cancer Statistics Registry in Japan. J Hepatobiliary Pancreat Surg 9(5):569–575Google Scholar
  37. 37.
    Lai EC, Lau WY (2005) Aggressive surgical resection for hilar cholangiocarcinoma. ANZ J Surg 75(11):981–985PubMedCrossRefGoogle Scholar
  38. 39.
    Miyazaki M, Ito H, Nakagawa K et al (1998) Aggressive surgical approaches to hilar cholangiocarcinoma: hepatic or local resection? Surgery 123(2):131–136PubMedGoogle Scholar
  39. 40.
    Gerhards MF, van Gulik TM, de Wit LT et al (2000) Evaluation of morbidity and mortality after resection for hilar cholangiocarcinoma—a single center experience. Surgery 127(4):395–404PubMedCrossRefGoogle Scholar
  40. 41.
    Schwarz RE, Smith DD (2007) Lymph node dissection impact on staging and survival of extrahepatic cholangiocarcinomas, based on U.S. population data. J Gastrointest Surg 11(2):158–165PubMedCrossRefGoogle Scholar
  41. 42.
    Tojima Y, Nagino M, Ebata T et al (2003) Immunohistochemically demonstrated lymph node micrometastasis and prognosis in patients with otherwise node-negative hilar cholangiocarcinoma. Ann Surg 237(2):201–207PubMedCrossRefGoogle Scholar
  42. 43.
    Taniguchi K, Tabata M, Iida T et al (2006) Significance of lymph node micrometastasis in pN0 hilar bile duct carcinoma. Eur J Surg Oncol 32(2):208–212PubMedCrossRefGoogle Scholar
  43. 44.
    Jarnagin WR, Shoup M (2004) Surgical management of cholangiocarcinoma. Semin Liver Dis 24(2):189–199PubMedCrossRefGoogle Scholar
  44. 45.
    Ramacciato G, Corigliano N, Mercantini P et al (2006) [Prognostic factors after surgical resection for hilar cholangiocarcinoma] Ann Chir 131(6–7):379–85, FrenchPubMedGoogle Scholar
  45. 45.
    Sobin LH, Wittekind C (eds) (2002) TNM classification of malignant tumours, 6th edn. Wiley, New YorkGoogle Scholar

Copyright information

© Springer 2008

Personalised recommendations